Search
RV1 and RV5 were both effective in preventing laboratory confirmed and notified rotavirus infections among children aged <5 years
This study provides a quantitative estimate of the total burden of invasive pneumococcal disease preventable by vaccination programs in Australia
Pneumococcal nasopharyngeal carriage prevalence and density were higher in infants delivered vaginally compared with those delivered by cesarean birth
Streptococcus pneumoniae causes substantial morbidity and mortality among children. The introduction of pneumococcal conjugate vaccines (PCV) has the potential to dramatically reduce disease burden. As with any vaccine, it is important to evaluate PCV impact, to help guide decision-making and resource-allocation.
Severe hospitalized varicella still occurs with a 1-dose varicella program, although predominantly in unvaccinated children
No significant associations were found between maternal inactivated influenza vaccine or pertussis vaccination in pregnancy and adverse birth outcomes
One dose of MenACWY-TT boosts protection against MenC in primed children, is safe and extends protection against MenA, MenW and MenY
Overall, the 2016 influenza vaccine showed good protection against laboratory-confirmed infection among general practice patients
Vaccine-proximate febrile seizures accounted for a small proportion of all febrile seizures hospital presentations
This large population-based study suggests a significant healthcare burden associated with influenza in children with a range of chronic lung diseases